Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Davis Jerel. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Davis Jerel har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:TSBX / Turnstone Biologics Corp. | Director | 0 |
US:KDNY / Chinook Therapeutics Inc | Director | 0 |
US:RPTX / Repare Therapeutics Inc. | Director | 25 131 |
US:GRPH / Graphite Bio, Inc. | Director, 10% Owner | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Davis Jerel. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp RPTX / Repare Therapeutics Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i RPTX / Repare Therapeutics Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel RPTX / Repare Therapeutics Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i RPTX / Repare Therapeutics Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Davis Jerel som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −82 006 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −90 888 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −207 486 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −2 726 322 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −274 990 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −210 996 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −719 104 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −2 105 107 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −447 013 | 0 | −100,00 | ||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 5 939 | 82 006 | 7,81 | 12,00 | 71 268 | 984 072 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 6 575 | 90 888 | 7,80 | 12,00 | 78 900 | 1 090 656 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 15 028 | 207 486 | 7,81 | 12,00 | 180 336 | 2 489 832 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 197 458 | 2 726 322 | 7,81 | 12,00 | 2 369 496 | 32 715 864 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 274 990 | 274 990 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 76 067 | 76 067 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 84 313 | 84 313 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 192 458 | 192 458 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 2 528 864 | 2 528 864 | |||||
2023-05-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 300 | 733 770 | 0,45 | ||||
2023-04-19 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −295 808 | 443 713 | −40,00 | 20,75 | −6 138 223 | 9 207 355 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −36 751 | 210 996 | −14,83 | 22,75 | −836 085 | 4 800 159 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −123 249 | 719 104 | −14,63 | 22,75 | −2 803 915 | 16 359 616 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −240 000 | 2 105 107 | −10,23 | 22,75 | −5 460 000 | 47 891 184 | |
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 014 | 25 131 | 13,63 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 721 | 0 | −100,00 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 721 | 4 721 | |||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −21 854 | 42 877 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 240 | 22 117 | 5,94 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −65 957 | 0 | −100,00 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 065 | 65 957 | 3,23 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −9 561 | 18 761 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 866 | 63 892 | 3,01 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −8 638 | 16 949 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 62 026 | 62 026 | |||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −287 157 | 563 403 | −33,76 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 739 521 | 0,22 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 465 | 0 | −100,00 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 865 | 9 465 | 162,92 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −108 715 | 247 747 | −30,50 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −364 587 | 842 353 | −30,21 | ||||
2022-12-13 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −250 000 | 2 094 451 | −10,66 | 16,00 | −4 000 000 | 33 511 216 | |
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 384 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 9 384 | 9 384 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 975 | 737 875 | 0,27 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −11 359 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 359 | 11 359 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −567 963 | 2 345 107 | −19,50 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 316 | 735 900 | 0,18 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −7 570 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 4 692 | 7 570 | 163,03 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −86 972 | 356 462 | −19,61 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 878 | 2 878 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −291 670 | 1 206 940 | −19,46 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 734 584 | 0,22 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 466 | 0 | −100,00 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 866 | 9 466 | 162,94 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −108 715 | 443 434 | −19,69 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −364 587 | 1 498 610 | −19,57 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 448 | 20 877 | 44,69 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −10 099 | 0 | −100,00 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 10 099 | 10 099 | |||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −46 753 | 64 731 | −41,94 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 653 | 14 429 | 22,53 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −141 103 | 0 | −100,00 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 419 | 141 103 | 3,23 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −20 454 | 28 322 | −41,93 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 992 | 136 684 | 3,01 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −18 478 | 25 587 | −41,93 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 132 692 | 132 692 | |||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −614 315 | 850 560 | −41,94 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −33 395 | 111 484 | −23,05 | 12,25 | −409 146 | 1 365 869 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −14 611 | 48 776 | −23,05 | 12,25 | −179 010 | 597 589 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −13 199 | 44 065 | −23,05 | 12,25 | −161 710 | 539 871 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −438 795 | 1 464 875 | −23,05 | 12,25 | −5 375 985 | 17 947 209 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −250 000 | 2 344 451 | −9,64 | 12,25 | −3 062 925 | 28 723 510 | |
2022-05-16 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −11 726 | 0 | −100,00 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 726 | 11 726 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 468 | 732 938 | 0,34 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −14 194 | 0 | −100,00 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 14 194 | 14 194 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | X | −709 953 | 2 913 070 | −19,60 | |||
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −92 000 | 552 149 | −14,28 | 16,00 | −1 472 018 | 8 834 494 |
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −308 000 | 1 863 197 | −14,19 | 16,00 | −4 928 062 | 29 811 525 |
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 000 | 3 623 023 | −14,21 | 16,00 | −9 600 120 | 57 969 093 |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −78 098 | 644 149 | −10,81 | 14,00 | −1 093 372 | 9 018 086 | |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −261 902 | 2 171 197 | −10,76 | 14,00 | −3 666 628 | 30 396 758 | |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −510 000 | 4 223 023 | −10,78 | 14,00 | −7 140 000 | 59 122 322 | |
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −2 260 | 0 | −100,00 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 260 | 2 260 | |||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 19 | 11 776 | 0,16 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −2 279 | 0 | −100,00 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 279 | 2 279 | |||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −152 071 | 231 211 | −39,68 | |||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
C - Conversion | −3 715 415 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
C - Conversion | −30 019 945 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
P - Purchase | 180 000 | 1 707 719 | 11,78 | 17,00 | 3 060 000 | 29 031 223 | |
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 1 527 719 | 1 527 719 | |||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 12 343 727 | 14 708 398 | 522,01 | ||||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
A - Award | 3 715 415 | 3 715 415 | 5,06 | 18 800 000 | 18 800 000 | ||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
A - Award | 10 000 000 | 30 019 945 | 49,95 | 1,00 | 10 000 000 | 30 019 945 | |
2021-06-24 | 3 | GRPH |
Graphite Bio, Inc.
Common Stock |
2 364 671 | ||||||||
2021-06-07 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 5 948 | 5 948 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 119 | 0 | −100,00 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 119 | 1 119 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 9 | 11 757 | 0,08 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 128 | 0 | −100,00 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 128 | 1 128 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −75 000 | 383 282 | −16,37 | ||||
2021-05-14 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 912 | 11 748 | 8,42 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −3 473 | 0 | −100,00 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 473 | 3 473 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −16 079 | 144 879 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 930 | 10 836 | 21,67 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −48 528 | 0 | −100,00 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 520 | 48 528 | 3,23 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −7 035 | 63 387 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 373 | 47 008 | 3,01 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −6 355 | 57 264 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 45 635 | 45 635 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −211 277 | 1 903 670 | −9,99 | |||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 906 | 0,07 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 458 282 | −9,84 | |||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 176 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 176 | 5 176 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 824 | 8 900 | 10,20 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −6 000 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 000 | 6 000 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −300 000 | 2 594 451 | −10,36 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 076 | 0,07 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 508 282 | −8,96 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 313 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 313 | 4 313 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 687 | 8 070 | 9,31 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 000 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 000 | 5 000 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −250 000 | 2 894 451 | −7,95 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 764 | 7 383 | 59,84 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 328 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 328 | 4 328 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −20 037 | 160 958 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 820 | 4 619 | 65,02 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −60 472 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 893 | 60 472 | 3,23 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −8 766 | 70 422 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 711 | 58 579 | 3,01 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −7 919 | 63 619 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 56 868 | 56 868 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −263 278 | 2 114 947 | −11,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 2 799 | 0,21 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 558 282 | −8,22 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 744 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 744 | 4 744 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 756 | 2 793 | 37,11 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 500 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 500 | 5 500 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −275 000 | 3 144 451 | −8,04 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 975 | 2 037 | 91,81 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 388 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 388 | 1 388 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −11 688 | 180 995 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 062 | 1 062 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −35 276 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 105 | 35 276 | 3,23 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −5 113 | 79 188 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 998 | 34 171 | 3,01 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −4 620 | 71 538 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 33 173 | 33 173 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −153 579 | 2 378 225 | −6,07 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −21 707 | 192 683 | −10,13 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −9 497 | 84 301 | −10,12 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −8 579 | 76 158 | −10,12 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −285 217 | 2 531 804 | −10,12 | |||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Stock Option (right to buy) |
A - Award | 23 522 | 23 522 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 2 433 099 | 2 433 099 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 722 247 | 722 247 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 4 733 023 | 4 733 023 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 730 470 | 730 470 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −458 282 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −875 568 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −3 350 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −3 708 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −8 475 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −111 361 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −2 443 883 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −61 791 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −68 398 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −156 335 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −2 054 198 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 100 000 | 3 419 451 | 3,01 | 20,00 | 2 000 000 | 68 389 020 | |
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 150 000 | 608 282 | 32,73 | 20,00 | 3 000 000 | 12 165 640 | |
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 458 282 | 458 282 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 875 568 | 3 319 451 | 35,83 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 350 | 84 737 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 708 | 93 798 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 8 475 | 214 390 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 111 361 | 2 817 021 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 443 883 | 2 443 883 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 61 791 | 81 387 | 315,32 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 68 398 | 90 090 | 315,31 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 156 335 | 205 915 | 315,32 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 054 198 | 2 705 660 | 315,32 | ||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 |